{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:03:24Z","timestamp":1770883404998,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":1770,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL126974"],"award-info":[{"award-number":["R01HL126974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007149"],"award-info":[{"award-number":["T32HL007149"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005881","name":"Hemostasis and Thrombosis Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1111\/jth.13887","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T10:02:39Z","timestamp":1509184959000},"page":"131-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin \u03b1\u2010chain crosslinking"],"prefix":"10.1016","volume":"16","author":[{"given":"J.D.","family":"Beckman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Holle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-2303","authenticated-orcid":false,"given":"A.S.","family":"Wolberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13887_bb0010","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V91.12.4581","article-title":"Blood coagulation in hemophilia A and hemophilia C","volume":"91","author":"Cawthern","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V99.3.923","article-title":"Mechanism of factor VIIa\u2010dependent coagulation in hemophilia blood","volume":"99","author":"Butenas","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1538-7836.2009.03306.x","article-title":"Discordant fibrin formation in hemophilia","volume":"7","author":"Brummel\u2010Ziedins","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0025","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1182\/blood-2010-06-291906","article-title":"Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery","volume":"116","author":"Dargaud","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2141.1984.tb06121.x","article-title":"The haemostatic plug in haemophilia A: a morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A","volume":"58","author":"Sixma","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13887_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05820.x","article-title":"High dose factor VIIa enhances clot stability in a model of hemophilia B","volume":"131","author":"Wolberg","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13887_bb0045","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13887_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1160\/TH16-02-0116","article-title":"Inhibitor incidence in previously untreated patients with severe haemophilia B: a systematic literature review","volume":"116","author":"Franchini","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MBC.0000000000000582","article-title":"Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry","volume":"27","author":"Kessler","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13887_bb0060","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1160\/TH09-02-0135","article-title":"Fibrin gel structure obtained with a FVIIa analogue with enhanced FX\u2010activating potential in haemophilia","volume":"102","author":"He","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/hae.12627","article-title":"Efficacy and safety of OBI\u20101, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A","volume":"21","author":"Kruse\u2010Jarres","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13887_bb0070","first-page":"e93","article-title":"Recombinant porcine factor VIII for high\u2010risk surgery in paediatric congenital haemophilia A with high\u2010titre inhibitor","volume":"22","author":"Croteau","year":"2017","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13887_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/hae.12873","article-title":"Pro\u2010 and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA((R)) in prophylactic therapy","volume":"22","author":"Varadi","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13887_bb0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clinthera.2012.01.001","article-title":"Efficacy of bypassing agents in patients with hemophilia and inhibitors: a systematic review and meta\u2010analysis","volume":"34","author":"Zhou","year":"2012","journal-title":"Clin Ther"},{"key":"10.1111\/jth.13887_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.2011.08854.x","article-title":"Parallel use of by\u2010passing agents in haemophilia with inhibitors: a critical review","volume":"155","author":"Ingerslev","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13887_bb0090","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/hae.12095","article-title":"Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors","volume":"19","author":"Valentino","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13887_bb0095","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/hae.12723","article-title":"Should anti\u2010inhibitor coagulant complex and tranexamic acid be used concomitantly?","volume":"21","author":"Valentino","year":"2015","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/jth.13887_bb0100","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0268-960X(15)30006-0","article-title":"Safety update on the use of recombinant activated factor VII in approved indications","volume":"29","author":"Neufeld","year":"2015","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13887_bb0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia A mortality in the United States","volume":"90","author":"Walsh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13887_bb0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-291X(74)80275-5","article-title":"Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen","volume":"56","author":"Lorand","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/jth.13887_bb0115","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1073\/pnas.0504120102","article-title":"The elasticity of an individual fibrin fiber in a clot","volume":"102","author":"Collet","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13887_bb0120","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2005-05-2150","article-title":"The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis","volume":"106","author":"Collet","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1160\/TH13-10-0855","article-title":"Roles of fibrin alpha\u2010 and gamma\u2010chain specific cross\u2010linking by FXIIIa in fibrin structure and function","volume":"111","author":"Duval","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0130","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1172\/JCI75386","article-title":"Factor XIII activity mediates red blood cell retention in venous thrombi","volume":"124","author":"Aleman","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13887_bb0135","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2015-06-652263","article-title":"Factor XIIIa\u2010dependent retention of red blood cells in clots is mediated by fibrin alpha\u2010chain crosslinking","volume":"126","author":"Byrnes","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1111\/jth.13887_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJMc1113270","article-title":"Factor XIII in the treatment of hemophilia A","volume":"366","author":"Rea","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13887_bb0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1538-7836.2010.04171.x","article-title":"Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A","volume":"9","author":"Rea","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jth.12478","article-title":"FXIII: mechanisms of action in the treatment of hemophilia A","volume":"12","author":"Rea","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0160","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1002\/pbc.24478","article-title":"Treatment of refractory hemorrhage with factor XIII in a patient with hemophilia A with inhibitor","volume":"60","author":"Ng","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/jth.13887_bb0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI110479","article-title":"Significance of cross\u2010linking of alpha 2\u2010plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis","volume":"69","author":"Sakata","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13887_bb0170","doi-asserted-by":"crossref","first-page":"14767","DOI":"10.1016\/S0021-9258(18)33346-5","article-title":"Cross\u2010linking of alpha 2\u2010plasmin inhibitor to fibrin catalyzed by activated fibrin\u2010stabilizing factor","volume":"257","author":"Tamaki","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13887_bb0175","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2013-08-523860","article-title":"Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin","volume":"123","author":"Cines","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0180","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/ATVBAHA.111.229088","article-title":"Lytic resistance of fibrin containing red blood cells","volume":"31","author":"Wohner","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13887_bb0185","doi-asserted-by":"crossref","first-page":"24915","DOI":"10.1074\/jbc.M002901200","article-title":"Cross\u2010linking of plasminogen activator inhibitor 2 and alpha 2\u2010antiplasmin to fibrin(ogen)","volume":"275","author":"Ritchie","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13887_bb0190","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1182\/blood-2011-02-333203","article-title":"The antifibrinolytic function of factor XIII is exclusively expressed through alpha(2)\u2010antiplasmin cross\u2010linking","volume":"117","author":"Fraser","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0195","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/jth.13354","article-title":"Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII","volume":"14","author":"Rijken","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/hae.12524","article-title":"Efficacy and safety of prophylactic treatment with plasma\u2010derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency","volume":"21","author":"Ashley","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13887_bb0205","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1111\/hae.12591","article-title":"The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency \u2013 the first experience","volume":"21","author":"Arokszallasi","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13887_bb0210","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/j.1538-7836.2010.04028.x","article-title":"Factor XIII \u2013 an under diagnosed deficiency \u2013 are we using the right assays?","volume":"8","author":"Lawrie","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13887_bb0215","doi-asserted-by":"crossref","first-page":"e48172","DOI":"10.1371\/journal.pone.0048172","article-title":"Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody\u2010specific inhibition","volume":"7","author":"Doshi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13887_bb0220","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood.V99.9.3235","article-title":"Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model","volume":"99","author":"Singh","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.13887_bb0225","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.thromres.2011.06.027","article-title":"Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis","volume":"129","author":"Emmerechts","year":"2012","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13887","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622036431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622036431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13887\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:18:54Z","timestamp":1761535134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622036431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1538783622036431"],"URL":"https:\/\/doi.org\/10.1111\/jth.13887","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin \u03b1\u2010chain crosslinking","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}